BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
1.680
+0.040 (2.44%)
At close: Oct 21, 2026, 4:00 PM EDT
1.650
-0.030 (-1.79%)
After-hours: Oct 21, 2026, 7:30 PM EDT
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $31.22 million as of October 21, 2026. It is the 33,686th most valuable company in the world and the 4,938th biggest in the United States.
Market Cap
31.22M
Enterprise Value
25.48M
1-Year Change
n/a
Global Rank
Country Rank
#4,938 United States
Category
ChartMarket Cap Chart
Since August 7, 2026, BioStem Technologies's market cap has decreased from $69.50M to $31.22M, a decrease of -55.08%. That is a compound annual growth rate of -98.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 29.30M | 6.55% |
| Oct 19, 2026 | 27.50M | -26.27% |
| Oct 16, 2026 | 37.30M | 2.47% |
| Oct 15, 2026 | 36.40M | -3.45% |
| Oct 14, 2026 | 37.70M | -6.22% |
| Oct 13, 2026 | 40.20M | -7.80% |
| Oct 12, 2026 | 43.60M | -1.13% |
| Oct 9, 2026 | 44.10M | -6.37% |
| Oct 8, 2026 | 47.10M | 10.30% |
| Oct 7, 2026 | 42.70M | -3.17% |
| Oct 6, 2026 | 44.10M | -10.37% |
| Oct 5, 2026 | 49.20M | 1.03% |
| Oct 2, 2026 | 48.70M | -11.13% |
| Oct 1, 2026 | 54.80M | -0.72% |
| Sep 30, 2026 | 55.20M | -19.30% |
| Sep 29, 2026 | 68.40M | -5.39% |
| Sep 28, 2026 | 72.30M | -2.17% |
| Sep 25, 2026 | 73.90M | 6.64% |
| Sep 24, 2026 | 69.30M | 2.21% |
| Sep 23, 2026 | 67.80M | -4.51% |
| Sep 22, 2026 | 71.00M | -9.55% |
| Sep 21, 2026 | 78.50M | -7.21% |
| Sep 18, 2026 | 84.60M | 8.74% |
| Sep 17, 2026 | 77.80M | 6.87% |
| Sep 16, 2026 | 72.80M | 1.68% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 34.93M |
| CervoMed | 34.62M |
| Evaxion | 33.78M |
| Filana Therapeutics | 33.26M |
| GridAI Technologies | 32.79M |
| Aligos Therapeutics | 31.41M |
| Metagenomi Therapeutics | 31.40M |
| BriaCell Therapeutics | 30.41M |